Lundbeckfonden Ventures News

OXFORD, UK - 16 April 2015 - PsiOxus Therapeutics Ltd. (PsiOxus), an oncolytic immunoncology company, has announced that it will present data highlighting the progress of its next generation Antibody Armed EnAd" (AbEnAd) anti-cancer therapeutic platform at the American Association for Cancer Research (AACR) Annual Meeting 2015 in Philadelphia, PA April 19-22, 2015. AbEnAd is...
Phase I Study Results Confirming Intravenous Delivery Profile and Repeated Dosing Leads to Expansion of the Clinical Programme into New Indications
Financing will be used to grow CERAMENTT platform and expand market penetration
LEXINGTON, Mass., April 14, 2015 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that it has elected Dorothy A. Coleman to its board of directors and that it has appointed Brian Piekos as Chief Financial Officer. 
SAN DIEGO and POMPEY, France, March 24, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage cardiovascular gene therapy company and Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming...
Niemann-Pick Disease experts Drs. Paul Gissen, Marc Patterson and Forbes D. Porter, along with biopharmaceutical industry leader Dr. Cristina Csimma, join Vtesse in quest to develop new treatments for people facing Niemann-Pick Disease Type C and rare diseasesGAITHERSBURG, Md., March 25, 2015 /PRNewswire/ -- Vtesse, Inc.,  a rare disease company focused on developing drugs for Niemann-Pick Disease...
Cambridge, UK - 3rd March 2015: Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces that Scott Byrd and Christine Soden have joined its Board of Directors.
Lund, Sweden, (PRNEWSWIRE) February 25, 2015 - BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced that it has received regulatory approval from the CDSCO (Central Drugs Standards Control Organization) and their MDAC (Medical Device Approval Committee) to market CERAMENTT'BONE VOID FILLER and...
LEXINGTON, Mass. /PRNewswire/ – scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that Pieter Muntendam, President, CEO and founder of scPharmaceuticals, will present at Leerink Global Healthcare Conference in New York, NY on February 11, 2015. Dr. Muntendam will provide an update on the company beginning at 11:30...
1 42 43 44 45 46 64

Lundbeckfonden Ventures


Horizon Therapeutics plc Acquires Curzion Pharmaceuticals, Inc. and Its LPAR1 Antagonist Product Candidate to Expand Development-Stage Pipeline
3. April 2020
Acacia Pharma Group PLC – Publication of Prospectus
25. March 2020
Acacia Pharma Group PLC – Forthcoming 2020 Annual General Meeting – Change of Venue and Proxy Forms
23. March 2020